Periprocedural stroke is a rare but life-threatening complication of percutaneous coronary intervention (PCI). Transradial intervention (TRI) is more beneficial than transfemoral intervention for periprocedural bleeding and acute kidney injuries, but its effect on periprocedural stroke has not been fully investigated. Our study aimed to assess risk predictors of periprocedural stroke according to PCI access site.
P
eriprocedural stroke after percutaneous coronary intervention (PCI) is a rare but serious complication; it is associated with high mortality and impaired quality of life. 1, 2 Although the incidence of other PCI-related complications such as in-hospital mortality and bleeding has declined over the last decade, 3, 4 that of periprocedural stroke has not declined to the same extent. 1, 2, 5 Recently, the use of transradial intervention (TRI) has considerably increased 6 mainly because TRI has been shown to decrease the incidence of major adverse events, including bleeding and acute kidney injury compared with traditional transfemoral intervention (TFI), as seen in several large-scale randomized trials. [7] [8] [9] However, the potential of TRI to reduce periprocedural stroke has not been clarified. Historically, there was a strong concern that TRI may be associated with an increased risk of periprocedural stroke, as the guiding catheter is introduced through the subclavian artery, which is adjacent to the common carotid artery and vertebral artery, both of which directly supply the brain. 10 Exploratory outcome analyses of 2 randomized trials and several meta-analyses showed no difference in stroke rates between TRI and TFI. 7, 8, 11, 12 However, as few patients experienced periprocedural stroke events in these trials, they were statistically underpowered. Randomized controlled trials also possess limitations such as inability to reflect a diversity of patients or clinical circumstances in daily practice as well as controls for the experience of interventionists. Therefore, data from real-world registries on the epidemiological association between periprocedural stroke and the access site are of paramount importance. A few observational studies have been performed for evaluating the effect of TRI on periprocedural stroke compared with TFI 13, 14 ; however, they were performed during the implementation period of TRI, and generalization of these studies is not guaranteed.
We therefore aimed to assess the clinical predictors of periprocedural stroke, with particular attention to the procedural access site, within a contemporary multicenter PCI registry.
METHODS
The article adheres to the AHA Journals' implementation of the Transparency and Openness Promotion Guidelines (http://www.ahajournals.org/TOP-guidelines). The data and materials used to conduct this research are available to researchers for purposes of reproducing the results or replicating the procedure on request. The procedure does need to follow the Act on the Protection of Personal Information Law (as of May 2017) and the Ethical Guidelines for Medical and Health Research Involving Human Subjects (as of March 2015) in Japan.
Study Design
The JCD-KiCS (Japan Cardiovascular Database-Keio Interhospital Cardiovascular Studies) is a large, ongoing, prospective multicenter cohort registry that is designed to collect clinical data on PCI patients. 15 Patients were enrolled at the time of PCI, and consecutive cases, including failure cases, were registered between July 2008 to April 2016. All PCIs were performed under the direction of the intervention team of each participating hospital according to standard practice. To obtain a robust assessment of the care and patient outcomes, the baseline data and outcomes were collected from the medical record by onsite clinical research coordinators (CRCs) who were trained by the primary investigator (S. Kohsaka) and project coordinator (I. Ueda). The data were entered into an electronic data-capturing software system, which has a robust data query engine and system validations for data quality. In addition, to ensure the accuracy of the adverse events, KiCS PCI was supported by an events committee that adjudicates major procedural complications (eg, death or cardiac and cerebrovascular events). Initially, all procedural complications are reviewed by a trained CRC under the supervision of the project coordinator and categorized into those in need of adjudication and those that were clearly not related to cardiovascular or index procedures. A single events committee member reviewed the abstracted record; a second or third adjudicator was used in the event of disagreement between the project coordinator and first adjudicator. Because the generalizability of all observational studies can be affected by selective enrollment of some patients (eg, those with successful versus unsuccessful procedures), it is critically important to ensure complete enrollment of consecutive patients. To address this, a unique feature of KiCS PCI is that each of the assigned
WHAT IS KNOWN
• Periprocedural stroke is a rare but devastating complication of percutaneous coronary intervention. • Transradial intervention has been shown to reduce the risk of periprocedural bleeding and acute kidney injury compared with transfemoral intervention.
• However, its effect on periprocedural stroke has not been fully investigated, particularly in the present transradial-dominant era.
WHAT THE STUDY ADDS
• Our analyses using a contemporary multicenter registry showed that transradial intervention was associated with a reduced risk of stroke after percutaneous coronary intervention, compared with transfemoral intervention, regardless of its indications; this conclusion was reached after rigorous statistical adjustments for potential confounders.
• Increased transradial intervention use may aid in reducing this significant complication; it should be recommended as the optimal access site for both urgent/emergent and elective percutaneous coronary interventions.
CRCs had direct access to the institutional procedure ledger for PCI procedures. All the CRCs had the ability to link to the ledger for auditing enrollment. All the KiCS PCI investigators and institutions agreed to release their data on the ledger to the assigned CRC. The process was used to audit enrollment and ensure a truly a consecutive cohort or account for any under-reporting of failed or complicated procedures. This study was approved by each center's ethics review committee. All participants provided written informed consent.
The clinical variables in JCD-KiCS were defined according to the American College of Cardiology-sponsored National Cardiovascular Data Registry CathPCI registry to enable comparative research between the United States and Japan and investigate disparities in PCI management.
Inclusion and Exclusion Criteria
All 17 966 consecutive PCI patients, including acute and elective cases, were initially included in this study. Exclusion criteria are listed in Figure 1 . We excluded patients who presented with out-of-hospital cardiac pulmonary arrest (n=180, 1.0%), cardiogenic shock (n=133, 0.7%), and those who used intraaortic balloon pumps (n=1174, 6.5%) because it is clinically impossible to distinguish procedure-related stroke from hemodynamic stroke in these patients. Patients on hemodialysis (n=697, 3.9%) were excluded because TRI is deemed impractical for this group. After exclusion, the final study population consisted of 13 909 PCI patients.
Definitions
Periprocedural stroke was defined as a loss of neurological function caused by an ischemic or hemorrhagic event with residual symptoms lasting at least 24 hours after onset or leading to death. 2 For patients with extended hospital stays, we restricted the coding of postprocedure events to 30 days after the last procedure, in accordance with the definition provided by the National Cardiovascular Data Registry. 2 PCI from the radial or brachial artery was defined as TRI, whereas PCI from the femoral artery was defined as TFI. Access site crossover from TRI to TFI was categorized as TFI. The choice of left or right TRI/ TFI was not assessed in the current registry, but the right-sided approach has been the preferred access for most TRI procedures in Japan. 16 Chronic kidney disease (CKD) was defined as an estimated glomerular filtration rate <60 mL min −1 1.73 m −2 , which is compatible with the Kidney Disease Outcomes Quality Initiative and Kidney Disease Improving Global Outcomes guideline classification stage 3 or higher. 17 To accommodate for missing preprocedural estimated glomerular filtration rate data, we substituted the value with postprocedural estimated glomerular filtration rate data, if available. Cerebrovascular disease was defined as any previous history of stroke. Previous heart failure was defined as hospitalization because of heart failure. Multivessel coronary lesion was defined as coronary artery disease involving ≥2 coronary arteries. Coding for atrial fibrillation was added in 2012, and its status was available for patients registered after 2012 (52.6%). The remaining clinical variables and in-hospital outcomes of the JCD-KiCS registry were defined in accordance with the National Cardiovascular Data Registry version 4.1. 
Statistical Analysis
First, we compared the demographics and in-hospital outcomes of patients with and without periprocedural stroke. Continuous variables with normal distribution were expressed as mean±SD, others as median (interquartile range), and categorical data as counts and percentages. Statistical comparison of baseline characteristics and outcome was performed using the independent-sample t test for continuous variables and the Pearson χ 2 test or Fisher exact test, as appropriate, for categorical variables. Multivariable logistic regression analysis was performed to assess variables that were independently associated with the incidence of stroke. Incorporated variables were age, sex, CKD, peripheral artery disease (PAD), acute coronary syndrome (ACS), previous heart failure, and TRI. These variables were determined according to their clinical relevance and statistical significance in association with the incidence of stroke.
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Second, we conducted a propensity score (PS)-matching analysis to assess the impact of TRI and TFI on incident stroke in a matched cohort based on the PS calculated from all potentially unbalanced baseline covariates. PS was calculated for each patient using a logistic regression model predicting the selection into TRI treatment group from the following variables that were considered as important outcome risk factors as well as factors used for selecting the access site: age, sex, body mass index, previous myocardial infarction, previous heart failure, diabetes mellitus, cerebrovascular disease, PAD, chronic obstructive pulmonary disease, hypertension, history of smoking within 1 year, dyslipidemia, history of PCI, history of coronary artery bypass graft, ACS, CKD, multivessel disease, type C lesion, and time trend (2010-2016 as categorical). Matching was performed with a 1:1 matching protocol without replacement, using a caliper width equal to 0.2 of the SD of the PS. The balance between the TRI and TFI groups in the matched cohort was estimated using absolute standardized difference. First, multivariable logistic regression analysis was performed to assess variables that were independently associated with the incidence of stroke. Second, propensity score-matching analysis was performed to assess the impact of transradial intervention (TRI) and transfemoral intervention (TFI) on incident stroke. IABP indicates intra-aortic balloon pump; KiCS, Keio Interhospital Cardiovascular Studies; and PCI, percutaneous coronary intervention.
Furthermore, we assessed how the information on catheter manipulation and procedure complexities such as the number of intracoronary devices used, fluoroscopy time (corresponding to the procedure time), and contrast medium dose affected the outcome by constructing a model including these potential confounders. Here, we conducted multivariable regression analysis including procedure complexity among patients in the matched cohort.
Prespecified subgroup analyses were performed for age (over 75 years versus under), sex, clinical setting (ACS versus stable angina pectoris), presence of CKD, presence of PAD, and presence of type C lesion after PS-matching analysis. We also conducted an additional analysis restricted to patients treated at moderate-to high-volume centers (annual PCI case volume ≥200). The restriction was applied to repeat the assessment under the minimized effect of center volume, which has been reported to be associated with clinical outcomes of PCI. 19 To confirm the consistency of our results across different PS analysis methods, we conducted the following additional analyses. (1) Inverse probability of treatment weight analysis with individual's weight calculated as follows: Pr (TRI)/PS for those exposed to TRI, and (1−Pr (TRI))/(1−PS) for those not expose to TRI where Pr (TRI) is the marginal possibility of being exposed. 20 These weights were truncated at 10 to avoid large variance in our estimate because of excessively large weight. 21 The CI for the inverse probability of treatment weight analysis was assessed using the robust variance estimator. 22 (2) Logistic regression analysis with adjustment for PS as a continuous variable.
Finally, sensitivity analysis using an approach proposed by Schneeweiss 23 was performed to investigate how the observed odds ratio (OR, 0.33 in this analysis) may be affected by certain variations in the assumptions about the presence of an unmeasured binary confounder. Three-dimensional mesh plots were constructed to evaluate the impact of varying unmeasured confounder settings (ie, the presence of an unmeasured confounder with differing prevalence in the TRI or TFI group, with varying strength of association with the outcome) on the observed OR.
All P values were 2-sided. Results were considered statistically significant at P <0.05. All statistical analyses were performed with SPSS version 23.0.0 (SPSS Inc, Chicago, IL) and R version 3.1.0.
RESULTS

Study Population
Of the 13 909 patients included in the study, 42 (0.3%) developed periprocedural stroke. The crude incidence of stroke declined over the study period, whereas TRI usage during the same time frame increased from 28% in 2009 to 82% in 2015 (Figure 2) . Table 1 summarizes the baseline characteristics of the study cohort stratified according to the presence of periprocedural stroke. Patients with stroke were older, female, had a higher incidence of CKD and PAD, and were more likely to present with ACS. There was no significant difference in atrial fibrillation prevalence among patients with stroke and without stroke. Patients with stroke were less likely to have undergone TRI than TFI (21.4% versus 46.8%; P=0.001). In addition, patients with stroke were more likely to experience in-hospital bleeding and blood transfusion compared with patients without stroke (16.7% versus 1.9%, P<0.001; and 11.9% versus 1.1%, P<0.001, respectively).
Predictors of Periprocedural Stroke
Among the 13 909 patients included in the multivariable logistic regression analysis, TRI was significantly associated with a reduced risk of periprocedural stroke (OR, 0.33; 95% CI, 0.16-0.71; P=0.004) after adjustment for patients' age, sex, presence of CKD, PAD, previous heart failure, and whether or not the patient had ACS. CKD (OR, 2.30; 95% CI, 1.18-4.47), ACS (OR, 2.32; 95% CI, 1.21-4.44), and PAD (OR, 2.54; 95% CI, 1.14-5.66) were also significant predictors of periprocedural stroke (Figure 3) .
PS Analysis
The prematching study population consisted of 13 909 procedures: 6496 patients (46.7%) underwent TRI, whereas 7413 patients (53.3%) underwent TFI ( Table 2) . Overall, patients with TRI and TFI had a similar patient profile. As a result, the logistic model for the PS had a C statistic of 0.71, and the distribution of receiving TRI over TFI largely overlapped between the TRI group and TFI group ( Figure S1 in the Data Supplement). The PS matching generated 4363 pairs of patients. The groups in the matched cohort had similar baseline characteristics, confirmed by the absolute values of standardized mean differences <0.03 for all variables ( The change in the estimated OR after including the proxies of catheter manipulation and procedure complexity was not substantial for the analysis of stroke. The inclusion moved the estimate away from the null, and TRI remained associated with a reduced risk of periprocedural stroke compared with TFI (OR, 0.24; 95% CI, 0.07-0.87; P=0.03; Table 3 ).
Subgroup analyses, representing the OR of TRI for periprocedural stroke, showed that TRI was consistently associated with a lower likelihood of periprocedural stroke, even among those treated at high-volume centers ( Figure 4) .
The results from inverse probability of treatment weight analysis yielded an estimate that is consistent with the results of our PS-matched analysis (OR, 0.28; 95% CI, 0.11-0.72; P=0.008). Adjustment for PS as a linear term in the model also yielded an estimate that is consistent with the findings in the main analysis (OR, 0.33; 95% CI, 0.14-0.79; P=0.012).
Sensitivity Analysis
Result of the sensitivity analysis is shown in Figure 5 . The curved surface represents what the OR for stroke would be, if an additional adjustment for a hypothetical unmeasured confounder was possible. Here, we assumed a prevalence of 40% for the hypothetical confounder in the unexposed group (TFI). As represented by the black thick line, when the prevalence of the confounder is also at 40% in the exposed group, the additional adjustment for the variable does not affect the estimation of the OR, and it remains at 0.33. When the prevalence of the confounder in the exposed group is higher, assuming that the confounder has a positive effect on the risk of stroke (relative risk [RR] >1), the additional adjustment for the variable will bring the estimated OR down, further away from the null. When the prevalence of the confounder is smaller in the exposed group (moving toward the right on the Pc1 axis), the adjusted OR increase towards the null, in varying levels depending on the strength of association between the confounder and the outcome (upward on the RR CD axis). An OR of 0.8 is only achieved when an additional adjustment for a confounder with 1/10 the prevalence in the exposed and an association with the outcome of RR CD =5.0 and above. 
DISCUSSION
Periprocedural stroke is a clinically significant complication associated with high mortality and morbidity during PCI. To our knowledge, our study is the first to demonstrate the favorable effect of TRI on reduction of periprocedural stroke in a large-scale PCI registry.
The robustness of our results was confirmed through rigorous statistical analysis: PS-matching analysis, subgroup analysis, and sensitivity analysis.
Although there is a concern that TRI may be associated with an increased risk of periprocedural stroke because of anatomic reasons, 10 meta-analyses showed no difference in the stroke rates between TRI and TFI, 11, 12 nor did Values are mean±SD or n (%). ACS indicates acute coronary syndrome; BMI, body mass index; CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; PCI, percutaneous coronary intervention; TRI, transradial intervention; and TFI, transfemoral intervention.
*Chronic kidney disease was defined as an estimated glomerular filtration rate <60 mL min 7, 8 However, almost all analyses were conducted using data from the TFI era, whereas our registry presents evidence obtained from routine care data in the contemporary TRI era. As the mechanisms of periprocedural stroke are strongly related to procedures, such as catheter manipulation, the learning curve of procedures may have influenced previous results. Our study is unique in that the data were obtained from Japanese institutions, where TRI was introduced earlier than in Western countries. 6, 24 Furthermore, randomized trials have challenges, such as controlling for the experience of interventionists and the selective nature of populations. It is important to continuously re-examine the association between stroke and access site in more contemporary observational studies especially in the case of rare but significant and irreversible neurological events such as periprocedural stroke.
Radial intervention (especially right sided, as is favored in Japan) involves less catheter contact with the aortic arch when compared with TFI. 16, 25 The aortic arch is a particularly vulnerable site for heavy atherosclerotic plaque and is therefore an established risk factor of embolic events. 26, 27 Pathologically, aortic atherosclerosis typically begins in the abdominal portion and progresses retrograde with near-sparing of the ascending portion; with these anatomic distributions, dislodging plaque is easier when performing TFI than when performing TRI; TRI would completely spare the abdominal and descending thoracic portions of the aorta (the sites where the maximum plaque is found). 27 Previously, Jurga et al 10 demonstrated that TRI used for coronary angiography generates more particulate cerebral microemboli than TFI and thus may influence the occurrence of silent cerebral injuries. Although these results are interesting, the occurrence of more clinically significant symptomatic stroke should perhaps be examined separately from the occurrence of silent cerebral microemboli. The difference between our results and those of Jurga et al 10 suggested that manipulation in the subclavian artery may cause silent cerebral microemboli; otherwise, clinically relevant cerebral infarction may originate from large plaques mainly located in the aortic arch.
The lower bleeding rate observed in the TRI group may have also led to a reduction in the incidence of stroke. Patients with stroke were more likely to have bleeding complications and blood transfusion compared with patients without stroke; in our study, the majority of patients with stroke and bleeding underwent TFI. Previous studies have suggested that anemia and hypotension secondary to major bleeding are closely related to cerebral ischemia, in part explained by decreased oxygen delivery and tissue hypoperfusion. [28] [29] [30] Blood transfusion could be also associated with an increased risk of stroke through transfusion-enhanced systemic inflammatory reaction, causing a prothrombotic environment. 31, 32 The widespread use of TRI may have reduced the rate of bleeding complications and blood transfusions, which may indirectly lead to a reduced incidence of stroke.
Limitations
Several limitations of our study should be noted. First, some of the factors suggested to have associations with the outcomes were not adjusted because of lack of relevant information in the database. These unmeasured potential confounding factors include the presence of anticoagulation therapy, catheter size, and ejection fraction. Furthermore, because this is an observational study, there may be unknown and unmeasurable factors that are confounding the relationship between access site and postprocedural stroke. However, our sensitivity analysis showed that our results are robust in almost all plausible scenarios. Second, the incidence of periprocedural stroke was noted in a small number of patients; therefore, the multivariable model we developed needs to be interpreted with caution and requires further validation in other regions with a higher number of events. However, as mentioned above, because of its rare incidence, it is unrealistic to plan a significant randomized controlled trial; thus, large-scale observational databases like our registry are needed to assess the occurrence. Moreover, we performed PS matching to confirm the robustness of the result. Importantly, even after adjusting for many covariates including the time trend, the same result was obtained. Third, we had no data about brain imaging studies that would be valuable to understand the mechanism of stroke. We could not identify whether the cause of stroke was the anatomic catheter contact or hemodynamic reasons. In addition, the choice of left or right TRI/TFI was not assessed in the current registry. However, recent studies reported that left-sided TRI is associated with a reduced risk of PCI-related in-hospital stroke complications compared with right-sided TRI. 33 This favorable result of left-sided TRI would not affect the robustness of TRI if some patients underwent left-sided TRI. Although the right-sided approach is the preferred access for most TRI procedures, information on exact laterality would have aided in our analysis. We also did not capture the number of crossover cases switching from TRI to TFI. However, our previous study reported access site crossover cases from TRI to TFI were observed only in 2.9% of patients undergoing TRI. 16 In this study, anatomic variation, defined as abnormal origin of the radial artery and radioulnar loop and tortuous configuration, was an independent predictor of transradial procedure failure. This study suggested that almost all crossover cases change the access site from the radial to the femoral artery before the catheters or wires can reach the subclavian arteries. Thus, crossover cases are acceptable to be included in the TFI group. Fourth, the operators were not formally qualified on the basis of the number of TRIs performed as in clinical trials. However, our study is unique in that the data were obtained from Japanese institutions, where TRI was introduced relatively early compared with Western countries. 6, 24 Indeed, the volume of contrast medium used for TRI patients was lower compared with the volume described in other registries. 34, 35 Finally, our analysis may have been affected by multiple comparisons conducted because of the additions of a secondary analysis. Chance may have exaggerated the results of our secondary analysis.
Conclusions
TRI was associated with a reduced risk of periprocedural stroke compared with TFI. Increased TRI use may aid in reducing overall PCI complications and thus should be recommended as the optimal access site for both ACS and elective PCIs. The observed odds ratio (OR) was set at 0.33. The prevalence of unmeasured confounders in the transfemoral intervention (TFI) group was set at 0.40 (P C0 ). Two factors were varied: the strength of the unmeasured confounder-outcome association (RR CD , 1.0-5.0) and the prevalence of the unmeasured confounder in the transradial intervention (TRI) group (P C1 , 0.0-0.5). A 3-dimensional mesh plot was constructed to check the impact on the observed OR by varying presence and strength of association with the outcome for the confounder. All adjusted ORs were <1 on the plotted surface, indicating that our estimate for the main analysis is robust to the presence of most realistic scenarios of an unobserved confounder. P C0 indicates prevalence of confounder in the exposed; P C1 , prevalence of confounder in the unexposed; and RR CD , relative risk between confounder and disease outcome.
